Pharmaceutical drug refers to a substance created to treat, prevent, or cure an illness or other condition, or to lessen its symptoms. To list the most popular methods, drugs can be consumed orally, through a skin patch, by injection, or through an inhaler. Other vital medications made from natural materials include vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics. The main types of pharmaceutical drugs are cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are used to treat medical conditions associated with the heart or the circulatory system (blood vessels), such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others. The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmaceutical drugs market is expected to grow from $ 1,136.23 billion in 2022 to $1,199.86 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The pharmaceutical drugs market is expected to reach $1,848.49 billion in 2027 at a CAGR of 11.4%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. China and India together had about 193.4 million diabetic patients in 2019 and India is expected to have about 101 million diabetic patients by 2030, thereby increasing the need for biologics drugs for diabetic patients. These factors are expected to increase the patient pool globally, thereby driving the pharmaceutical drug market during the forecast period. Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period, this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates rose to 3.5% by 2021. These factors are expected to hurt the market as borrowing money becomes expensive, thereby affecting the pharmaceuticals market growth. Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion was generally observed at a phase nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product. Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. For example, in 2020, FDA has switched three prescription drugs to OTC including Voltaren for arthritis pain, olopatadine hydrochloride 0.1% and 0.2% (Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes due to pollen, ragweed, and grass. Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S.A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co and CJ Corp. North America was the largest region in the pharmaceutical drugs market in 2022. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical drugs market is segmented - 1) By Type: Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels 3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs Subsegments Covered: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs), Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases, Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals, Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overactive Bladder, Drugs For Infections And Others, Drugs For Hormonal Replacement Therapy, Diuretics, Blood Products, Anemia And Other Blood Disorder Drugs, Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal), Anti Diabetics drugs, Anti-Thyroid Drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism), Drugs For Rheumatoid Arthritis, Muscle Relaxants, Other Musculoskeletal Disorders Drugs, Analgesics, Anti-Parkinson drugs, Anesthetics, Anti-Epileptics, Other CNS drugs, Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Cancer Drugs, Brain Tumor Drugs, Thyroid Cancer Drugs, Skin Cancer Drugs, Bladder Cancer Drugs, Cervical Cancer Drugs, Blood Cancer Drugs, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma), Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy), Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations

Pharmaceutical packaging equipment refers to the equipment comprised of multiple equipment and its components, piping, instruments, electrical items and other related accessories which are all fabricated and assembled at the shop and usually mounted on the skid which are ready for connection and used for packaging of all pharmaceutical products, using flexible, and heat sealable material to form packages that are filled with a product and then sealed. The main types of products of pharmaceutical packaging equipment are primary packaging equipment, secondary packaging equipment, and labeling and sterilization equipment. Primary packaging equipment is in direct contact with the product itself and is referred to as a consumer unit. Primary packaging is what directly encases and contains the drug product. Secondary packaging equipment provides corrugated cardboard packaging print finished to a high standard. Secondary packaging is the exterior packaging of the primary packaging that groups packages and further protects or labels the drug product. Labeling and sterilization equipment is responsible for adding directions of use and sterilizing the packaging environment. The various types of pharmaceutical packaging equipment are blenders, granulators, tablet pressers, tablet coating machines, and allied machines. The pharmaceutical packaging equipment market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical packaging equipment market statistics, including pharmaceutical packaging equipment industry global market size, regional shares, competitors with a pharmaceutical packaging equipment market share, detailed pharmaceutical packaging equipment market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical packaging equipment industry. This pharmaceutical packaging equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical packaging equipment market size grew from $9.94 billion in 2022 to $11.06 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical packaging equipment market size is expected to grow to $16.34 billion in 2027 at a CAGR of 10.2%. An increase in ageing population is expected to increase the prevalence of age-related ailments, thus contributing to the growth of the pharmaceutical drugs and pharmaceutical packaging equipment market. The elderly population is increasing rapidly across the world, and it is expected to continue over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC) report, the population aged 65 years and above is expected to reach approximately 71 million by 2030 and 98 million by 2060 in the USA. It is estimated by 2030, China will have nearly half of the Parkinson’s disease population in the world, which can be attributed to the country’s aging population. This expected increase in the aging population suffering from age-related ailments is projected to drive the pharmaceutical packaging equipment market. The automatic packaging machine is increasingly utilized in the pharmaceutical packaging equipment market. The machine automatically supplies packing materials and contents, and other machines of the packaging process can be done automatically. For instance, in July 2020, OPTIMA Packaging Group, a Germany based company that designs and builds packaging equipment for pharmaceutical, consumer, nonwovens, and life science products, launched OPTIMA FPA. It is a unique platform that can assemble pen injectors both fully or semi-automatically. It is especially suitable as an entry-level system. Another new feature of the Optima FPA is the choice of adding a printer connected with 360-degree labeling. This product launch has increased the company’s automated packaging solutions portfolio. In February 2021, ProMach, a US-based packaging machinery company, acquired Serpa Packaging Solutions for an undisclosed amount. The addition of Serpa brings automated cartoning systems into ProMach’s portfolio and significantly expands ProMach’s specialized secondary packaging machinery and line integration capabilities for the rapidly growing pharmaceutical industry. Serpa Packaging Solutions is a US-based company that designs and manufactures pharmaceutical packaging equipment. Major players in the pharmaceutical packaging equipment market are Körber AG, Uhlmann Group, Marchesini Group S.p.A., Optima Packaging Group, Romaco Holding GmbH, MG2 s.r.l., Robert Bosch GmbH, Industria Macchine Automatiche S.p.A., Vanguard Pharmaceutical Machinery, Accutek Packaging Equipment Companies, MULTIVAC Group, Bausch + Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG, ACG Group, Coesia S.P.A., Syntegon Technology, Trustar Pharma & Packing Equipment, Inline Filling Systems, Dara Pharmaceutical Packaging, ARPAC LLC, Romaco Group, N.K.P. Pharma, Ropack, and Trustar Pharma & Packing Equipment. North America was the largest region in the pharmaceutical packaging equipment market in 2022. Asia-Pacific was the second-largest market in the pharmaceutical packaging equipment market. The regions covered in the pharmaceutical packaging equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pharmaceutical packaging equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The pharmaceuticals packaging equipment market consists of sales of accumulating and collating machines, blister packs, skin packs and vacuum packaging machines, bottle caps equipment, over-capping, lidding, closing, seaming and sealing machines, box, case, tray, and carrier forming, packing, unpacking, closing, and sealing machines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical packaging equipment market is segmented - 1) By Product: Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterialization Equipment 2) By Packaging Type: Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment 3) By Equipment Type: Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines 4) By Mode of Administration: Injectable Administration, Topical Administration, Oral Administration

Pharmaceutical excipients refer to components of a drug delivery system that are not active pharmaceutical ingredients (API) but have undergone acceptable safety evaluation. Excipients, which are not active themselves, allow the drug ingredient to be administered to the patient in the proper form and support the mode and site of action. The main types of products in pharmaceutical excipients are inorganic chemicals and organic chemicals. The pharmaceutical inorganic chemical industry is concerned with the manufacture, physical or chemical characteristics of substances, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. The different functionalities include fillers and diluents, suspending and viscosity agents, coating agents, bindeflavoringring agents sweetenersners, disintegrants, colorants, lubric, ants, and glidants, and others and involve various formulations such as oral formulation, topical formulation, and parental formulation. The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical excipients market statistics, including pharmaceutical excipients industry global market size, regional shares, competitors with a pharmaceutical excipients market share, detailed pharmaceutical excipients market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. This pharmaceutical excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmaceutical excipients market grew from $8.6 billion in 2022 to $9.11 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical excipients market is expected to grow from $11.55 billion in 2027 at a CAGR of 6.1%. The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market. Generic drugs are alternatives to the marketed brand-name drug in the same dosage form, safety, strength, route of administration, and quality. According to India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines, the country’s generic drugs account for 20% of the global generic drug exports. Indian pharmaceutical companies received 300 generic drug approvals in the USA. The surge in the demand for generic drugs drives the pharmaceutical excipients market. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. According to the Pharmaceutical Journal, there are certain complications in children with the use of pharmaceutical drugs with excipients. For instance, the colourants used in medicine as colouring agents may lead to sensitivity reactions and hyperactive behaviour in children. Ethanol is another solvent that is widely used in an oral liquid formulation, the use of ethanol mixed medicine for children may have a risk of acute intoxication when overdose, and it may lead to chronic toxicity with long-term use. Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market. The increase in research and development in pharmaceutical formulation to enhance the production process and product quality by using multi-functional excipients is a trend shaping the market. Excipients play a significant role in helping pharmaceutical manufacturers better support patients by increasing compliance and treatment effectiveness. For instance, Evonik’s newly launched EUDRAGIT FS 100 is a solid version of the existing EUDRAGIT FS 30 D. This new multi-functional version allows pharmaceutical companies to use the polymer in many new applications, such as hot-melt extrusion, solvent spray-drying, and solvent coating, which was impossible to achieve in past decades where only the aqueous version was available. In July 2021, Philip Morris International, a US-based cigarette and tobacco manufacturing company acquired Fertin Pharma for $820m. Through this acquisition, PMI will gain significant ability in developing, formulating, and marketing existing as well as new smoke-free platforms. Fertin Pharma is a Denmark-based company that manufactures pharmaceutical excipients. Major players in the pharmaceutical excipients market are, Archer Daniels Midland Co., Associated British Foods, Dow Chemical Company, Evonik, Croda International PLC., Ashland, BASF SE, The Lubrizol Corporation, and Roquette Frères. North America is the largest region in the pharmaceutical excipients market in 2022. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market during the forecast period. The regions covered in the global pharmaceutical excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are "factory gate values," that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical excipients market is segmented - 1) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavouring Agents And Sweetners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities 2) By Type Of Formulation: Oral Fromulation, Topical Formulation, Parental Formulation 3) By Product: Inorganic Chemicals, Organic Chemicals

Pharmaceutical processing seals refers to a seal that is used on process-connected equipment that is designed to be linked to an external system that contains process fluids in order to stop flammable or combustible process fluids from migrating into the wire system in non-hazardous zones or other classed locations. The main types of pharmaceutical processing seals are O-rings, gaskets, lip seals, D seals, and others. O-ring seals are used to prevent leaks from pumps, valves, cylinders, and connectors used in pharmaceutical processing. The different materials include metals, PTFE, silicone, nitrile rubber, EPDM, and others and are used in various applications such as manufacturing equipment, agitators, mixers, reactors, gearboxes, and others. The pharmaceutical processing seals market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical processing seals market statistics, including pharmaceutical processing seals industry global market size, regional shares, competitors with a pharmaceutical processing seals market share, detailed pharmaceutical processing seals market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical processing seals industry. This pharmaceutical processing seals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical processing seals market size grew from $2.04 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 10.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical processing seals market size is expected to grow to $3.12 billion in 2027 at a CAGR of 8.4%. The rise in chronic diseases is significantly contributing to the growth of the pharmaceutical processing seals market. Chronic diseases are defined as conditions that last more than a year and require ongoing medical care; they are global, national health issues that involve mortality and morbidity. These include heart disease, cancer, and diabetes. The rise in chronic diseases is driving up demand for pharmaceuticals, which in turn is driving up demand for pharmaceutical processing seals. For instance, according to the International Diabetes Federation, in 2021, 537 million adults are suffering from diabetes worldwide, which is a huge increase compared to the 463 million adults living with diabetes in 2019. Technological advancements are shaping the pharmaceutical processing seals market. Major companies operating in the pharmaceutical processing seals sector are focused on developing new technological solutions to meet consumer demand and strengthen their position. For instance, in November 2021, Crawford Packaging, a UK-based packaging machines company launched Evolution S, the top seal packaging technology machinery with an advanced tray sealing solution manufactured by Packaging Automation Ltd. Evolution S - Packing Automation has developed the world's most efficient tray sealing technology, raising the bar for precision and fast sealing rates while decreasing the packaging area's necessary footprint in a single lane configuration. In April 2021, DXP Cortech, a US-based distributor of pumps and process equipment has partnered with John Crane for an undisclosed amount. Through this partnership, DXP Cortech will act as a distributor for John Crane products in the California region and the extended west coast markets. It will also enable both businesses to better service their customers and expand their operations. John Crane is a US-based company that manufactures pharmaceutical processing seals, filtration systems, couplings, and packing systems. Major players in the pharmaceutical processing seals market are Trelleborg AB, Freudenberg Group, Flowserve Corporation, James Walker & Co., Parker-Hannifin Corporation, Saint-Gobain S.A, Garlock Sealing Technologies, John Crane, IDEX Corporation, Marco Rubber and Plastics, Technetics Group, Sealmatic, Maffs Seals Pvt Ltd., Quantech Sealing Systems, and EagleBurgmann India Pvt. Ltd. North America was the largest region in the pharmaceutical processing seals market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical processing seals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical processing seals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceuticals processing seals market consists of sales of glass-to-metal seals, bodok seal, and a specialized gas sealing washer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical processing seals market is segmented - 1) By Type: O-rings, Gaskets, Lip seals, D seals, Other types (Diaphragms and X-rings) 2) By Material: Metals, PTFE, Silicone, Nitrile Rubber, EPDM, Other materials 3) By Application: Manufacturing Equipment, Agitators, Mixers, Reactors, Gear Boxes, Other applications

Pharmaceutical glass packaging refers to a type of glass container which is prepared by a combination of different materials that are designed to ensure the safe transportation of various acidic and medical items. The use of glass in pharmaceutical packaging has many benefits, as glass is incredibly resistant to temperature changes. The main types of pharmaceutical glass packaging are ampoules, bottles, vials, syringes, cartridges, and other products. The ampoules refer to the sealed glass-containing solutions for hypodermic injections. Ampoules are used as packaging for many cosmetic and pharmaceutical products. The various drug types include generics, branded, and biologics that are made of different materials, such as type I, type II, and type III. The several applications include oral, injectable, nasal, and others. The pharmaceutical glass packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical glass packaging market statistics, including pharmaceutical glass packaging industry global market size, regional shares, competitors with a pharmaceutical glass packaging market share, detailed pharmaceutical glass packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical glass packaging industry. This pharmaceutical glass packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical glass packaging market size grew from $12.58 billion in 2022 to $13.7 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical glass packaging market size is expected to grow to $18.89 billion in 2027 at a CAGR of 8.4%. The growth of the pharmaceutical industry is expected to propel the growth of the pharmaceutical glass packaging market going forward. The pharmaceutical industry refers to the discovery, development, and manufacture of medications and drugs. Pharmaceutical glass packaging is used to pack and store medicines, strong alkalis, and acids. For instance, in 2021, according to the Indian Brand Equity Foundation, an India-based government agency, the Indian pharmaceutical market increased by 17.7% annually, up from 13.7% in July 2020, and the market revenue is expected to be over 12% in 2022. Therefore, the growth of the pharmaceutical industry is driving the growth of the pharmaceutical glass packaging market. Technological innovations are the key trend gaining popularity in the pharmaceutical glass packaging market. Major companies operating in pharmaceutical glass packaging are introducing new technologies to reinforce their position in the market. For instance, in January 2020, Gerresheimer, a Germany-based manufacturer of pharmaceutical glass packaging and glass injections for patients, launched Gx Elite vials, which are manufactured by using new technology, Gx RHOC systems. GX Elite vials: this is a new type I borosilicate glass packaging. These are high-end tubular glass vials. This is the safest product for customers and patients. In May 2021, Nipro, a Japan-based company operating in pharmaceutical glass packaging, acquired Piramida for an undisclosed amount. The acquisition is expected to increase the production capacity of Nipro. also helps in the strong development of Nipro’s ampoules and vials business. Piramida is a Latvia-based company that manufactures pharmaceutical glass containers, with premium quality glass vials and ampoules. Major players in the pharmaceutical glass packaging market are Gerresheimer, Corning Inc., Nipro, Stolzle-Oberglas GmBH, Bormioli Pharma S.r.l, West Pharmaceutical Services, West Pharmaceutical Services, Schott AG, Beatson Clark, Sisecam, O-I Glass, Arab Pharmaceutical Glass Co., Acme Vial & Glass Co., Hindusthan National Glass & Industries Limited, and United Glass Company. North America was the largest region in the pharmacuetical glass packaging market in 2022. The regions covered in the pharmaceutical glass packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical glass packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical glass packaging market consists of sales of borosilicate glass, treated soda-lime glass, regular soda-lime glass, and general purpose soda-lime. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical glass packaging market is segmented - 1) By Product: Ampoules, Bottles , Vials, Syringes, Cartridges, Other Product Types 2) By Drug Type: Generic, Branded, Biologic 3) By Material: Type I, Type II, Type III 4) By Application: Oral, Injectable, Nasal, Other Applications

Pharmaceutical drug delivery refers to the process or method of administering a drug to an animal or human to achieve a therapeutic effect. It is a formulation or apparatus that allows a medicinal material to target its site of action while avoiding nontarget cells, organs, or tissues. The main types of pharmaceutical drug delivery routes of administration are oral, ocular, pulmonary, nasal, injectable, topical, and other routes. The oral route refers to the administration of a drug through the mouth, which is the most common route for drug administration due to its sustained and controlled delivery, ease of administration, and feasibility for solid dosage forms. The different pharmaceutical drug delivery applications include infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. The different end-users include hospitals, home care settings, ASC/Clinics, and other end users. The pharmaceutical drug delivery market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug delivery market statistics, including pharmaceutical drug delivery industry global market size, regional shares, competitors with a pharmaceutical drug delivery market share, detailed pharmaceutical drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug delivery industry. This pharmaceutical drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global pharmaceutical drug delivery market size grew from $1597.53 billion in 2022 to $1752.39 billion in 2023 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical drug delivery market size is expected to grow to $2075.25 billion in 2027 at a CAGR of 4.3%. The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market going forward. Prevalence of chronic diseases refers to the total number of existing cases of chronic diseases in a population at a specific time. Pharmaceutical drug delivery helps the patients suffering from chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases. For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally and cardiovascular diseases account for most of the deaths. Therefore, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery market. The adoption of nano-based drug delivery systems is a key trend gaining popularity in the pharmaceutical drug delivery market. The use of nanomaterials in pharmaceutical drug delivery can increase the cellular uptake of drugs because of the surface charge and time and they can increase the stability and water solubility of drugs. For instance, in March 2020, Bioavanta-Boston, a Switzerland-based chitosan nanoparticles research organization released Novochizol, unique polysaccharide nanotechnology that can be utilized to encapsulate any effective pharmaceutical additive such as a small molecule, or biologic for localized delivery and steady discharge in any organ or tissue, allowing for the treatment of severe COVID-19 infection in the lungs. In May 2022, Halozyme Therapeutics, a US-based biotechnology company acquired Antares Pharma for a deal amount of $960 million. With this acquisition, Halozyme targets to strengthen its position as a leading drug delivery company by including Antares specialty products. Antares Pharma is a US-based specialty pharmaceutical drug delivery company. Major players in the pharmaceutical drug delivery market are 3M Company, Bayer AG, Becton Dickinson And Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC., Johnson & Johnson Inc., Merck & Co Inc., Novartis AG, Pfizer Inc., Sanofi S.A., AbbVie Inc., Amgen Inc., AstraZeneca plc., Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., Kite Pharma, Nemera France SAS, Nimbus Therapeutics, SHL Medical AG., Teva Pharmaceuticals Industries Ltd., and West Pharmaceutical Services Inc., North America was the largest region in the pharmaceutical drug delivery market in 2022. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The pharmaceutical drug delivery market includes revenues earned by entities by administering a pharmaceutical compound to achieve a therapeutic effect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical drug delivery market is segmented - 1) By Route of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes 2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications 3) By End-User: Hospitals, Home Care Settings, ASC/Clinics, Other End Users

Pharmaceutical logistics refers to the integration of information flow, material handling, production, packaging, inventory, and chain management of prescription medicines. The main types of pharmaceutical logistics are cold chain logistics and non-cold chain logistics. Cold chain logistics refers to the technology and process that is used for the safe transport of goods that are temperature-sensitive along the supply chain. The different components in pharmaceutical logistics include storage, transportation, and monitoring components. The procedures include picking, storage, retrieval systems, and handling systems. Transporation includes sea freight, air freight, and overland. These are used in applications such as biopharma, chemical pharma, and specialty pharma. The pharmaceutical logistics market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical logistics market statistics, including pharmaceutical logistics industry global market size, regional shares, competitors with a pharmaceutical logistics market share, detailed pharmaceutical logistics market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical logistics industry. This pharmaceutical logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmaceutical logistics market size grew from $98.94 billion in 2022 to $109.34 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical logistics market size is expected to grow to $161.98 billion in 2027 at a CAGR of 10.3%. The rise in demand for pharmaceutical products is expected to propel the growth of the pharmaceutical logistics market going forward. Pharmaceutical products refer to any medicine that is for human use that is available in finished dosage form and is controlled by pharmaceutical legislation. Logistics help pharmaceutical products handle the procurement, storage, and transportation of resources. For instance, according to an article by India Brand Equity Foundation, an Indian government export promotion agency, in 2021 the Indian pharmaceutical market increased annually to 17.7% from 13.7% in July 2020. Therefore, a rise in demand for pharmaceutical products is driving the growth of the pharmaceutical logistics market. Technological advancements are a key trend gaining popularity in the pharmaceutical Logistics market. Major companies operating in the pharmaceutical logistics market are coming up with new technologies such as cloud-based supply chain functions, IoT technology, and others to sustain their position in the market. For instance, in May 2020, United Parcel Service, a US-based shipping, receiving, and supply chain management company, expanded its healthcare logistics with the launch of UPS Premier. UPS Premier is part of the company’s ongoing service and technology upgrades. It uses next-generation sensor technology and monitoring to improve service reliability with priority handling and improved visibility for critical healthcare packages. This technology is a major breakthrough for managing time-sensitive, temperature-sensitive, and patient-sensitive healthcare shipments. In March 2022, Lineage Logistics LLC, a US-based warehousing and logistics management company, acquired MTC Logistics for an undisclosed amount. This acquisition adds Lineage Logistics, four cold storage facilities along the U.S. East and Gulf Coasts, including 38M cubic feet and over 1.13lakh pallet positions. MTC Logistics is a US-based cold storage facility operating in the pharmaceutical logistics market. Major players in the pharmaceutical logistics market are Agility Public Warehousing Company K.S.C.P., Air Canada, CEVA Logistics, DB Schenker, Deutsche Post AG, FedEx Corporation, LifeConEx LLC, Marken, United Parcel Service , Kerry Logistics Network Limited, Panalpina, Kuehne + Nagel International AG, Sofrigam SA, CONTINENTAL Carriers Pvt Ltd and DSV A/S. North America was the largest region in the pharmaceutical logistics market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pharmaceutical logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The pharmaceutical logistics market includes revenues earned by entities by providing cold chain storage, asset ownership services, and quality management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global pharmaceutical logistics market is segmented - 1) By Type: Cold Chain Logistics, Non-Cold Chain Logistics 2) By Component: Storage, Transportation, Monitoring Components 3) By Procedure: Picking, Storage, Retrieval Systems, Handling Systems 4) By Transportation: Sea Freight, Air Freight, Overland 5) By Application: Bio Pharma, Chemical Pharma, Speciality Pharma

Pharmaceutical contract development and manufacturing refers to a business that offers services for drug research and manufacture within the pharmaceutical sector. Using CDMOs as a partner, pharmaceutical companies can outsource medication development and production. Full-service drug development and manufacturing outsourcing companies (CDMOs) can handle every stage of the process and work with clients that want to outsource specific steps in their workflow. Everything is based on the requirements of each client. The main types of pharmaceutical contract development and manufacturing organisations (CMO) are active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development and manufacturing, and secondary packaging. The active pharmaceutical ingredient (API) manufacturing includes the manufacturing of the part of any drug that produces the desired effects. The various research phases include preclinical, phase I, phase II, phase III, and phase IV. The different end-use sectors include big pharmaceutical companies, generic pharmaceutical companies, and small & medium-sized pharmaceutical companies. The pharmaceutical contract development and manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical contract development and manufacturing market statistics, including pharmaceutical contract development and manufacturing industry global market size, regional shares, competitors' pharmaceutical contract development and manufacturing market share, detailed pharmaceutical contract development and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical contract development and manufacturing industry. This pharmaceutical contract development and manufacturing market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global pharmaceutical contract development and manufacturing market grew from $122.31 billion in 2022 to $130.82 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pharmaceutical contract development and manufacturing market is expected to grow from $196.53 billion in 2027 at a CAGR of 10.7%. The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and raise the investment in their R&D to promote the development of new drugs. This impels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand for pharmaceutical contract development and manufacturing market. According to Alkermes PLC., a biopharmaceutical company indicates that pharmaceutical contract manufacturing will emerge as a strategic option for many companies ranging from very large to smaller specialty pharma entities and this mostly will happen because the pharmaceuticals companies are looking for cost-cutting. The pharmaceutical contract development and manufacturing market are restricted by the poor-capacity utilization of manufacturing facilities. The capacity utilization is calculated considering the full potential capacity of the production plant. The poor-capacity utilization of the production plant is caused due to the inefficiency of different sub-processes in the production line which results in low production. The low production output results in low revenue generation for the production unit, affecting the overall pharmaceutical contract development and manufacturing market. For instance, in January 2020, according to an article shared by Economic Times, an India-based English-language business-focused daily newspaper, The 1,500 API manufacturing facilities in India, according to the country's drug regulatory organisation, are only operating at 40% of their potential. Therefore, the usage of capacity of the production plant negatively affects the pharmaceutical contract development and manufacturing market. The companies in the pharmaceutical contract development and manufacturing market are investing in acquiring and forming alliances with other companies in the market. The pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition to expand their global market reach to meet the client needs, increase their production capabilities while maintaining cost efficiencies, and get access to the latest technology and new services. The high levels of merger and acquisition activities are resulting in the consolidation of the contract service providers. For instance, in July 2022, Pharma Nobis, a US-based provider of contract manufacturing and private label services, acquired Fagron’s U.S. contract manufacturing business for an undisclosed amount. Through this acquisition, Pharma Nobis is expected to offer contract manufacturing and private label services to American retailers and consumer healthcare corporations. 20% of the company will continue to be owned by Fagron. In August 2022, Catalent, Inc., a US-based provider of delivery technologies, development, and drug manufacturing, acquired Metrics Contract Services for $475 million. This acquisition is expected to improve Catalent's ability to work with highly potent chemicals while enhancing its expertise in integrated oral solid formulation research, production, and packaging to assist clients in streamlining and accelerating their processes. Metrics Contract Services is a US-based pharmaceutical contract development and manufacturing organization. Major players in the pharmaceutical contract development and manufacturing market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH, Aenova Group, Famar, Jubilant Life Sciences Limited, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals, HAUPT Pharma AG, Kemwell Pvt. Ltd., Nipro Corp., NextPharma, Royal DSM N.V., Althea Technologies, Thermo Fisher Scientific Inc., Lonza Group Ltd., AbbVie Inc., Consort Medical PLC., Almac Group, Siegfried Holding AG, Evonik Industries AG, and Vetter Pharma International GMBH. North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2022. The Middle East is expected to be the fastest growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the global pharmaceutical contract development and manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the pharmaceutical contract development and manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The pharmaceutical contract development and manufacturing market includes revenues earned by entities by providing drug development and manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global pharmaceutical contract development and manufacturing organisation (CMO) market is segmented - 1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging 2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV 3) By End-User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies